GlaxoSmithKline PLC Total Voting Rights (0559X)
03 May 2016 - 8:21PM
UK Regulatory
TIDMGSK
RNS Number : 0559X
GlaxoSmithKline PLC
03 May 2016
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with Disclosure and Transparency Rule 5.6.1R,
GlaxoSmithKline plc (the 'Company') hereby notifies the market of
the following:
The Company's issued share capital as at 30 April 2016 consisted
of 5,362,998,363 Ordinary Shares of 25p each, of which 491,505,950
Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is
4,871,492,413. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure and Transparency Rules.
V A Whyte
Company Secretary
3 May 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGUUPAUPQGUW
(END) Dow Jones Newswires
May 03, 2016 06:21 ET (10:21 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
